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Abstract 
Androgens act to stimulate spermatogenesis through androgen receptors (AR) on the 
Sertoli cells and peritubular myoid cells (PTM). Specific ablation of the AR in either cell 
type will cause a severe disruption of spermatogenesis. To determine whether androgens 
can stimulate spermatogenesis through direct action on the PTM alone or whether action 5 
on the Sertoli cells is essential we have crossed hypogonadal (hpg) mice which lack 
gonadotrophins and intratesticular androgen with mice lacking androgen receptors (AR)  
either ubiquitously (ARKO) or specifically on the Sertoli cells (SCARKO).  These 
hpg.ARKO and hpg.SCARKO mice were treated with testosterone (T) or 
dihydrotestosterone (DHT) for 7 days and testicular morphology and cell numbers 10 
assessed. Androgen treatment did not affect Sertoli cell numbers in any animal group.  
Both T and DHT increased numbers of spermatogonia and spermatocytes in hpg mice but 
DHT has no effect on germ cell numbers in hpg.SCARKO and hpg.ARKO mice. T 
increased germ cell numbers in hpg.SCARKO and hpg.ARKO mice but this was 
associated with  stimulation of FSH release. Results show  that  androgen stimulation of 15 
spermatogenesis requires direct androgen action on the Sertoli cells. 
 
Introduction 
Spermatogenesis is regulated by  follicle-stimulating hormone (FSH) and by androgen 
released from the Leydig cells in response to luteinising hormone (LH). In mice lacking 20 
androgen receptors (AR) either through a natural mutation (Tfm) or through genomic 
manipulation (ARKO) there is severe disruption to spermatogenesis with a failure of 
germ cells to progress beyond the early stages of meiosis (1;2). In contrast, mice lacking 
FSH or the FSH-receptor are fertile, albeit with reduced germ cell number (3-6), 
indicating that FSH acts primarily to optimise spermatogenesis and germ cell number 25 
while androgens are critical for the completion of meiosis and, therefore, fertility. 
In the adult animal testicular ARs are expressed in Sertoli cells, Leydig cells and 
peritubular myoid cells (PTMs) (2). The primary function of  the  Sertoli cells is to 
promote and maintain germ cell development through direct interaction with the cells and 
through generation of a unique microenvironment within the lumen of the seminiferous 30 
tubules. In mice lacking ARs only in the Sertoli cells (SCARKO) spermatogenesis is 
largely blocked at meiosis (2;7;8) although the disruption to spermatogenesis in the 
SCARKO is less marked than in the Tfm or ARKO mouse.  In addition to the SCARKO 
mouse,  it has recently been reported that mice lacking ARs in the  peritubular myoid 
cells (PTM-ARKO)  show severe depletion of germ cell numbers  and are infertile (9). 35 
This shows that androgen action through the PTMs is also essential for spermatogenesis 
and reveals a more complex interplay between endocrine stimulation, somatic cell 
activity and spermatogenesis than previously envisioned.   
To examine these interactions more closely and to determine whether androgen 
can acutely stimulate spermatogenesis without a direct effect on the  Sertoli cell we have 40 
generated mice lacking gonadotrophins and Sertoli cell androgen receptors by crossing 
SCARKO mice with hypogonadal (hpg) mice. The hpg mouse lacks circulating 
gonadotrophins (10) with a consequent loss of androgen production (11) and disruption to 
spermatogenesis (10). Treatment of  hpg.SCARKO mice with androgen will directly 
stimulate all androgen-sensitive testicular  cells apart from the Sertoli cell and show 45 
whether direct androgen action on the Sertoli cells is essential for germ cell development. 
 
Materials and Methods 
Animals and treatments 
All mice were bred and all procedures carried out under UK Home Office Licence and 50 
with the approval of a local ethical review committee. SCARKO and ARKO mice have 
been previously generated by crossing female mice carrying an Ar with a floxed exon 2 
(Arfl ) with male mice expressing Cre under the regulation of the Sertoli cell specific 
promoter Amh or the ubiquitous promoter Pgk-1 (2;12). The  hpg.SCARKO and 
hpg.ARKO mice were generated  as previously described (6;13). 55 
Adult mice (10 weeks) were treated with androgen by subcutaneous implantation of a 
2cm silastic capsule containing testosterone (T) or the non-aromatisable androgen 
dihydrotestosterone (DHT). Margaret?  Mice were killed one week after the start of 
treatment and testes snap frozen in liquid nitrogen or fixed overnight. Fixation was either 
in 4% paraformaldehyde/1%  gluteraldehyde in phosphate buffer (0.1M, pH 7.4) for 60 
preparation of semi-thin sections or in Bouin’s for subsequent morphometric analysis or 
immunohistochemistry. 
 
Hormone measurement 
Serum levels of FSH were measured by ELISA (IDS, Bolden, UK). 65 
 
Histology,  stereology and immunohistochemistry 
To prepare semi-thin (1μm) sections testes were embedded in araldite and sections 
stained with toluidine blue. For stereological analysis, testes were embedded in Technovit 
7100 resin, cut into sections (20μm), and stained with Harris’ hematoxylin. The total 70 
testis volume was estimated using the Cavalieri principle (14). The optical disector 
technique (15) was used to count the number of Sertoli cells and germ cells in each testis. 
Each cell type was identified by previously described criteria (16;17). The numerical 
density of each cell type was estimated using an Olympus BX50 microscope fitted with a 
motorized stage (Prior Scientific Instruments, Cambridge, UK) and Stereologer software 75 
(Systems Planning Analysis, Alexandria, VA, USA). Control data for this study includes 
data from a previous study (6) plus additional animals. 
 For immunohistochemistry,  testes were embedded in paraffin and sections (5 µm) 
were mounted on glass slides, dewaxed, and rehydrated. Sections were incubated with 
rabbit anti-AR antiserum (sc-816, Santa Cruz Biotechnology) following heat-induced 80 
antigen retrieval (2). Bound primary  antibody was detected using a peroxidase-
conjugated secondary antibody, followed by a fluorescyl-tyramide amplification step 
with visualization using 3,3-diaminobenzidine tetrahydrochloride (Dako UK Ltd, 
Cambridgeshire). For negative control samples, nonimmune serum  replaced primary 
antiserum.  85 
 
Statistical analysis 
Data were analysed using two factor analysis of variance (anova) with hormone treatment 
and animal group as the two variables. To show whether differences between individual 
groups were significant t-tests were employed using the pooled variance from the anova. 90 
Data were log transformed where appropriate to avoid heterogeneity of variance. Data on 
FSH levels were analysed by the non-parametric Kruskal-Wallis test followed by the Mann-
Whitney test. 
 
Results 95 
Androgen receptor expression 
Immunohistochemistry was used to localise ARs in the testes of hpg, hpg.SCARKO and 
hpg.ARKO mice (Fig 1). In the hpg testis ARs were clearly present in the PTMs and 
interstitial tissue with lighter staining apparent in the Sertoli cells (Fig 1A). In 
hpg.SCARKO mice there was clear staining for ARs in the PTMs and interstitial tissue 100 
while no specific staining was seen in the hpg.ARKO mice (Fig 1B & C). For 
comparison, testes from normal mice were included and  AR expression was apparent in 
Sertoli cells, PTMs and interstitial tissue (Fig 1D).   
 
Effect of androgen on  testis size, testis morphology and SV weight 105 
Hypogonadal mice are cryptorchid due to lack of post-natal androgen production. 
Prolonged androgen-treatment of these animal will induce testicular descent  but the 
duration of treatment in the experiments described here was insufficient to affect 
testicular localisation. Treatment of hpg and hpg.SCARKO mice with T or DHT did, 
however, increase testicular volume with the effect on hpg mice being more marked (Fig 110 
2). Surprisingly, T also increased the volume of hpg.ARKO mice but there was no effect 
of DHT (Fig 2).  
  Treatment of hpg mice with T or DHT  caused an increase in 
seminiferous tubule diameter (Figs 2 & 3), clear establishment of a tubular lumen and an 
apparent increase in germ cell number (Fig 3). In some tubules spermatogenesis 115 
progressed to the round spermatid stage following treatment with T (Fig 3).  Testosterone 
also increased tubule diameter in  hpg.SCARKO and hpg.ARKO mice but DHT only had 
an effect in hpg.SCARKO mice (Fig 2 & 3).   
 Seminal vesicle weights were significantly increased by T and DHT in both hpg 
and hpg.SCARKO mice (Fig 2). Due to a lack of ARs seminal vesicles do not develop in 120 
hpg.ARKO mice. 
 
Stereology 
Sertoli cell number was unaffected by androgen treatment in any animal group (Fig 4). 
Total germ cell number was increased by T in all three animal groups (Fig 5). In contrast, 125 
DHT  increased total germ cell number in hpg  mice but had no effect on hpg.SCARKO 
or hpg.ARKO mice (Fig 5). Similarly, T and DHT both increased spermatogonial and 
spermatocyte numbers in hpg mice but only T was effective in hpg.SCARKO and 
hpg.ARKO mice. Formation of round spermatids was limited mainly to hpg mice treated 
with T (Fig 5). A very small number of round spermatids were formed in hpg mice 130 
treated with DHT and hpg.SCARKO mice treated with T (Fig 5).  
 
FSH levels 
Serum FSH levels in hpg and hpg.ARKO mice were all below 1.5 ng/ml and in 
hpg.SCARKO mice  all levels were below the level of detection of the assay (0.2ng/ml) 135 
(Fig 6). For comparison, serum FSH levels in normal adult male mice are about 25ng/ml 
(18).  Treatment of  hpg,  hpg.SCARKO and hpg.ARKO mice with T caused a significant 
increase in serum FSH but DHT had no clear effect (Fig 6).  
 
Discussion 140 
Studies  with mice lacking functional ARs (Tfm or ARKO) have shown clearly that 
androgen is essential for  the onset of spermatogenesis (1;2). In addition, there is strong 
evidence from other models to indicate that androgens are critical for the maintenance of 
spermatogenesis. For example,  testosterone withdrawal appears to induce apoptosis of 
pachytene spermatocytes and round spermatids (19) and there is growing evidence that 145 
androgens are required for post-meiotic germ cell adhesion to the Sertoli cell (20-22). 
Since Sertoli cells express AR (23), germ cells do not express AR (23;24) and Sertoli 
cells are intimately involved in germ cell development it has appeared likely for some 
time that the major effects of androgen are mediated through the Sertoli cells. This has 
been re-enforced by the testicular phenotype of the SCARKO mouse which lacks germ 150 
cell development beyond the first meiotic division  (2). It is of considerable interest, 
therefore, that a recent study has reported major disruption to spermatogenesis  in mice 
lacking AR in the PTMs (9). Total loss of germ cells in these animals was greater than in 
SCARKO mice and appeared to be largely through disruption of the premeiotic cells (9).  
The results are all the more surprising since  Cre expression (and, therefore, AR ablation) 155 
occurred in less than 50% of PTMs. It is now clear, therefore, that androgens act to 
promote spermatogenesis through actions on both Sertoli cells and PTMs. To study this 
dual control in more detail we have used animal models based on the hpg mouse which 
lacks germ cell development and which is highly sensitive to androgen action (25;26). By 
combining hpg mice with SCARKO mice we have been able to determine whether 160 
androgens can stimulate spermatogenesis without direct effects through AR in the Sertoli 
cell. Results show that (non-aromatisable) androgen action through the PTMs (and 
Leydig cells) alone is insufficient to stimulate spermatogenesis in these animals and that 
direct androgen action on the Sertoli cells is essential. 
 The requirement for direct androgen action on the Sertoli cell to stimulate 165 
spermatogenesis may appear to be obvious from the phenotype of the SCARKO mouse 
(2). The major defect in this animal, however, is loss of post-meiotic cells  and this does 
not rule out additional direct spermatogenic effects of androgen through other cell types. 
In particular, pre-meiotic germ cell numbers are not markedly affected in the SCARKO 
mouse (spermatogonial numbers are normal and spermatocyte numbers are about 50-60% 170 
of normal (2;27)) indicating that androgen action through other cells  combined with  
FSH action on the Sertoli cells is sufficient to maintain reasonable pre-meiotic germ cell 
numbers. The phenotype of the FSHRKO and PTM-ARKO mice and the effects of FSH 
on the hpg would also be consistent with this hypothesis (3;6;9). In data reported here, 
however, the failure of DHT to stimulate tubule and germ cell development in the 175 
hpg.SCARKO mouse, in comparison to the hpg mouse,  shows that androgen stimulation 
of  spermatogonial and spermatocyte development requires direct action on the Sertoli 
cells. These experiments do not rule out the possibility that androgen action through the 
PTMs is also essential to stimulate spermatogenesis and studies using hpg.PTM-ARKO 
mice would clarify this. In addition, longer-term  direct effects of androgen through the 180 
PTMs, without direct effects on the Sertoli cells, cannot be excluded.  The 7-day time-
course was chosen for studies reported here because longer periods of androgen treatment 
will induce testicular descent in hpg and hpg.SCARKO mice which, in itself, will affect 
germ cell development.  
 A previous study has reported that T and DHT have similar effects on the 185 
development of spermatogenesis in the hpg  mouse over an 8-week time period (25). Our 
results largely confirm this report although DHT was less effective than T for the 
induction of round spermatid formation which may be due to the relatively short duration 
of the current study with attendant  lack of testicular descent.   Unexpectedly, however, 
we observed marked differences in the effects of T and DHT  on spermatogenesis in 190 
hpg.SCARKO and hpg.ARKO mice. These differences appear to be due to the induction 
of FSH release from the pituitary  by T but not DHT. In normal adult males androgens act 
to decrease circulating FSH primarily through effects on hypothalamic GnRH. In the hpg 
mouse, however, the primary effect of exogenous steroids is likely to be at the pituitary 
and there is evidence from in vivo and in vitro studies that T  can stimulate pituitary FSH 195 
and Fshb levels (28-31). More pertinently, so far as this study is concerned, it has also 
been shown that oestrogen will  increase circulating FSH levels in male hpg mice (32;33).  
The differential induction of FSH levels by T, but not by DHT, makes it highly likely that 
in our hpg models  aromatisation of T to oestrogen leads to stimulation of pituitary FSH 
release.  Differences between the effects of T and DHT on spermatogenesis in 200 
hpg.SCARKO and hpg.ARKO  mice can be attributed, therefore, to the effects of FSH 
which has been shown to stimulate spermatogenesis in both hpg.SCARKO and 
hpg.ARKO mice (6).  
  In summary, non-aromatisable androgen does not stimulate 
spermatogenesis in hpg mice lacking androgen receptors on the Sertoli cells. Androgen 205 
stimulation of spermatogenesis therefore requires direct androgen action on the Sertoli 
cells. 
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Figure Legends 
 
Figure 1 
Localisation of AR expression.. Immunohistochemistry was used to localize AR 315 
expression in adult testes from (A) hpg, (B) hpg.SCARKO, (C) hpg.ARKO and  
(D)normal mice. In the hpg testis ARs were clearly present in the PTMs (black arrows)  
and interstitial tissue with lighter staining apparent in the Sertoli cells (white arrows, cells 
identified by their nuclear shape and more prominent nucleolus). In hpg.SCARKO mice 
there was clear staining for ARs in the PTMs (black arrows) and interstitial tissue while 320 
no specific staining was seen in the hpg.ARKO mice. Apparent staining in the tubules is 
background staining. In normal mice AR expression was apparent in Sertoli cells, PTMs 
and interstitial tissue. The bar represents 20µm. 
 
Figure 2 325 
Effect of androgen on A) testis volume, B) tubule diameter and C) seminal vesicle weight 
in hpg, hpg.SCARKO and hpg.ARKO mice. Adult mice were treated with testosterone 
(T) or dihydrotestosterone (DHT) for 7 days. Results show the mean ± SEM for 3-6 
animals per group  in A) and B) and 9-36 animals per group in C).  Within a particular 
animal type, groups with different letter superscripts were significantly (P<0.05) 330 
different.  
 
Figure 3 
Semi-thin sections showing the effect of androgen on testicular morphology in hpg, 
hpg.SCARKO and hpg.ARKO mice. In untreated animals spermatogenesis was severely 335 
disrupted with only spermatogonia and some spermatocytes present. Treatment with T 
increased germ cell numbers in all mice although the effect was most marked in the hpg. 
Treatment with DHT increased germ cell number only in the hpg. In the hpg.ARKO 
group black arrows indicate the presence of microliths (13). The bar represents 20µm. 
 340 
Figure 4 
Effect of androgen on Sertoli cell number in hpg, hpg.SCARKO and hpg.ARKO mice. 
Adult mice were treated with testosterone (T) or dihydrotestosterone (DHT) for 7 days 
and cell numbers counted as described in Materials and Methods. Results show the mean 
± SEM for 3-6 animals per group.  Within a particular animal type, groups with different 345 
letter superscripts were significantly (P<0.05) different.  
 
Figure 5 
Effect of androgen treatment on the number of A) Total germ cells, B) Spermatogonia, C) 
Spermatocyte and D) Spermatids  in hpg, hpg.SCARKO and hpg.ARKO mice. Adult 350 
mice were treated with testosterone (T) or dihydrotestosterone (DHT) for 7 days and cell 
numbers counted as described in Materials and Methods. Results show the mean ± SEM 
for 3-6 animals per group.  Within a particular animal type, groups with different letter 
superscripts were significantly (P<0.05) different. No statistical analysis was applied to 
spermatid numbers. ND = not detected. 355 
 
Figure 6 
Serum levels of FSH in hpg, hpg.SCARKO and hpg.ARKO males treated with 
testosterone (T) or dihydrotestosterone (DHT) for 7 days. Results show values from 
individual animals in each group. The effect of testosterone was significant (P<0.05) in 360 
all three groups. 
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